Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Corticosteroids for viral central nervous system infections43
Complexities of cardiomyopathy in septic shock39
From diagnosis to management: current perspectives on congenital cytomegalovirus infection38
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era34
La Crosse virus encephalitis in children34
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel31
Editorial introductions29
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV29
Skin and soft tissue infections in the elderly27
Strongyloidiasis-related lung involvement: too much of a bad thing27
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes25
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response25
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians25
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside25
Surgical management of cystic echinococcosis of the liver25
Fusarium species central nervous system infection25
New therapies for nontuberculous mycobacterial lung infection24
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management23
Progress and challenges in human papillomavirus and cervical cancer in southern Africa23
Typhoid fever control in the 21st century: where are we now?22
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients22
Mycobacterial skin infection21
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?21
Tuberculosis molecular bacterial load assay in the management of tuberculosis20
Viral meningitis and encephalitis: an update20
Tick-borne encephalitis19
Resistant herpes simplex virus infections – who, when, and what's new?19
Malaria in pregnancy: baby steps19
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention19
Mpox in people living with HIV19
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?19
Appropriate surgical management in skin and soft tissue infections17
Does climate change threaten delivery of HIV care in resource-limited settings?17
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach17
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies17
Editorial introductions16
Gut microbiome and its clinical implications: exploring the key players in human health16
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis16
Diagnostic stewardship: what impacts antibiotics use?16
Diagnostic approach and update on encephalitis16
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV15
CMV antiviral stewardship in transplantation – the next frontier15
Using antibiotics wisely15
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles15
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections14
Immunotherapeutic approaches to HIV cure and remission14
Update on the treatment of chronic pulmonary aspergillosis14
The impact of coronavirus disease 2019 on people with HIV13
Risk stratification for selecting empiric antibiotherapy during and after COVID-1913
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change13
The microbiota in respiratory tract infections: from association to intervention13
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-1912
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential12
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities12
Editorial introductions12
Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy12
The plumbing problem: rising antimicrobial resistance in building water systems12
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae12
Childhood tuberculosis11
Interpreting and managing preservation fluids positive for Gram-negative bacteria11
Short treatment duration for community-acquired pneumonia11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans11
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management11
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients11
Respiratory metagenomics: route to routine service11
Update on drug treatments for multidrug resistant tuberculosis11
Editorial: Pathogenesis and immune response – editorial11
An overview of risk factors, management and prevention of cochlear implant infections11
The microbiome as a biomarker of anal precancerous lesions in people with HIV11
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives10
Short-course antibiotic strategies for ventilator-associated pneumonia10
The disease burden of respiratory syncytial virus in Infants10
Data science for pediatric infectious disease: utilizing COVID-19 as a model10
A new era of HIV care for age-associated multimorbidity10
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis10
Travellers’ diarrhoea – solidifying our knowledgebase10
Urinary tract infections in immunocompromised patients10
Editorial introductions9
Updates on the neurological manifestations of SARS-CoV-2 infection9
Novel techniques in the treatment of skin and soft tissue infection9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention9
Neurobrucellosis9
Identifying patients with difficult-to-treat acute bacterial skin infections9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity9
The role of Gram-negative bacteria in skin and soft tissue infections9
Skin and soft tissue infections in solid organ transplants9
Burden of influenza in the elderly: a narrative review9
0.2290940284729